Taisho said to near $1.6 billion deal for Bristol-Myers's UPSA: Bloomberg

Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

from Reuters: Business News https://ift.tt/2QAcSQI
via IFTTT